CA Patent

CA3073948A1 — Use of inhaled nitric oxide for the improvement of right and/or left ventricular function

Assigned to Bellerophon Pulse Technologies LLC · Expires 2019-03-07 · 7y expired

What this patent protects

Described herein are methods of using inhaled nitric oxide for improving and/or maintaining right ventricular function and/or left ventricular function. Some methods relate to the long-term administration of inhaled nitric oxide to a patient with pulmonary hypertension.

USPTO Abstract

Described herein are methods of using inhaled nitric oxide for improving and/or maintaining right ventricular function and/or left ventricular function. Some methods relate to the long-term administration of inhaled nitric oxide to a patient with pulmonary hypertension.

Drugs covered by this patent

Patent Metadata

Patent number
CA3073948A1
Jurisdiction
CA
Classification
—
Expires
2019-03-07
Drug substance claim
No
Drug product claim
No
Assignee
Bellerophon Pulse Technologies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.